Jane Street’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

Jane Street’s Portfolio CALT Stock Details CALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-12,491	Closed	-$191K	–	10368
2022 Q3	$191K	Buy	12,491 +886	+8%	+$15.4K	﹤0.01%	8218
2022 Q2	$210K	Buy	11,605 +62	+0.5%	+$1.08K	﹤0.01%	8136
2022 Q1	$221K	Buy	+11,543	New	+$231K	﹤0.01%	8896
2021 Q3	–	Sell	-7,216	Closed	-$211K	–	10931
2021 Q2	$211K	Buy	+7,216	New	+$206K	﹤0.01%	8741
2021 Q1	–	Sell	-7,557	Closed	-$256K	–	9698
2020 Q4	$256K	Sell	7,557 -2,721	-26%	-$82.8K	﹤0.01%	6626
2020 Q3	$244K	Buy	10,278 +1,243	+14%	+$29K	﹤0.01%	6170
2020 Q2	$219K	Buy	+9,035	New	+$179K	﹤0.01%	6255

Other funds holding CALT

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

IIM

Ironwood Investment Management Boston, Massachusetts $240M AUM 45.82% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

HSA

HBK Sorce Advisory Erie, Pennsylvania $5.05B AUM 16.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Jane Street's CALT Position: Q4 2022 in Review

Jane Street sold out of Calliditas Therapeutics AB American Depositary Shares (CALT) in Q4 2022, closing a stake of 12,491 shares — an estimated $191K sold.

Jane Street first reported a position in CALT in Q2 2020 and held it in 7 quarters. The position peaked at $256K in Q4 2020. 18 funds tracked by Wall St. Rank hold CALT as of Q4 2022.

Jane Street reported no remaining Calliditas Therapeutics AB American Depositary Shares position as of Q4 2022 after selling out during the quarter.
Jane Street sold 12,491 Calliditas Therapeutics AB American Depositary Shares shares in Q4 2022, an estimated $191K.
Jane Street first reported a position in Calliditas Therapeutics AB American Depositary Shares in Q2 2020 and held it in 7 quarters.
Jane Street's Calliditas Therapeutics AB American Depositary Shares position peaked at $256K in Q4 2020.
18 funds tracked by Wall St. Rank held Calliditas Therapeutics AB American Depositary Shares as of Q4 2022.

Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.